V. Mayaudon

652 total citations
13 papers, 565 citations indexed

About

V. Mayaudon is a scholar working on Biochemistry, Hematology and Management of Technology and Innovation. According to data from OpenAlex, V. Mayaudon has authored 13 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biochemistry, 7 papers in Hematology and 6 papers in Management of Technology and Innovation. Recurrent topics in V. Mayaudon's work include Blood transfusion and management (10 papers), Blood donation and transfusion practices (6 papers) and Platelet Disorders and Treatments (4 papers). V. Mayaudon is often cited by papers focused on Blood transfusion and management (10 papers), Blood donation and transfusion practices (6 papers) and Platelet Disorders and Treatments (4 papers). V. Mayaudon collaborates with scholars based in United States, Sweden and Germany. V. Mayaudon's co-authors include Laurence Corash, L. Lin, Lily Lin, C R Hind, D.J. van Rhenen, Folke Knutson, Kent Dupuis, Karin Janetzko, Jocelyne Flament and Harald Klüter and has published in prestigious journals such as Transfusion, Vox Sanguinis and Journal of Clinical Apheresis.

In The Last Decade

V. Mayaudon

13 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Mayaudon United States	11	421	265	261	74	49	13	565
Karin Janetzko Germany	13	252 0.6×	183 0.7×	161 0.6×	70 0.9×	37 0.8×	26	483
P. M. Ness United States	12	229 0.5×	246 0.9×	112 0.4×	49 0.7×	45 0.9×	17	507
Hervé Isola France	9	206 0.5×	122 0.5×	157 0.6×	45 0.6×	55 1.1×	21	385
Margaret Rheinschmidt United States	7	195 0.5×	140 0.5×	116 0.4×	26 0.4×	39 0.8×	9	281
C. Barrasso United States	9	258 0.6×	214 0.8×	145 0.6×	36 0.5×	44 0.9×	16	458
Alex Morrison United Kingdom	9	145 0.3×	174 0.7×	75 0.3×	37 0.5×	58 1.2×	16	378
K. Koerner Germany	14	127 0.3×	158 0.6×	89 0.3×	226 3.1×	27 0.6×	56	541
Frank Tolksdorf Germany	11	131 0.3×	82 0.3×	99 0.4×	23 0.3×	15 0.3×	14	458
Dheeraj Khetan India	13	137 0.3×	126 0.5×	137 0.5×	19 0.3×	18 0.4×	32	385
Julian B. Schorr United States	10	69 0.2×	120 0.5×	84 0.3×	85 1.1×	20 0.4×	17	385

Countries citing papers authored by V. Mayaudon

Since Specialization

Citations

This map shows the geographic impact of V. Mayaudon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Mayaudon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Mayaudon more than expected).

Fields of papers citing papers by V. Mayaudon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Mayaudon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Mayaudon. The network helps show where V. Mayaudon may publish in the future.

Co-authorship network of co-authors of V. Mayaudon

This figure shows the co-authorship network connecting the top 25 collaborators of V. Mayaudon. A scholar is included among the top collaborators of V. Mayaudon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Mayaudon. V. Mayaudon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sandgren, Per, et al.. (2009). Storage of buffy‐coat‐derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry‐over. Vox Sanguinis. 98(3p2). 415–422. 17 indexed citations

Gulliksson, H., et al.. (2009). Extended storage of whole blood before the preparation of blood components: in vitro effects on red blood cells in Erythro‐Sol environment. Vox Sanguinis. 96(3). 199–205. 8 indexed citations

Gallian, Pierre, C. Vignoli, V. Mayaudon, et al.. (2006). Inactivation of a European strain of West Nile virus in single‐ donor platelet concentrate using the INTERCEPT blood system. Vox Sanguinis. 91(4). 345–347. 13 indexed citations

Isola, Hervé, Daniel Kientz, Boris Aleil, et al.. (2005). In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set. Vox Sanguinis. 90(2). 128–130. 9 indexed citations

Janetzko, Karin, Jean‐Pierre Cazenave, Harald Klüter, et al.. (2005). Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion. 45(9). 1443–1452. 102 indexed citations

Janetzko, Karin, et al.. (2005). Polymerase chain reaction inhibition assay documenting the amotosalen‐based photochemical pathogen inactivation process of platelet concentrates. Transfusion. 45(9). 1464–1472. 12 indexed citations

Janetzko, Karin, L. Lin, Hermann Eichler, et al.. (2004). Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets. Vox Sanguinis. 86(4). 239–245. 51 indexed citations

Frohlich, A. A., et al.. (2004). In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days. Journal of Clinical Apheresis. 19(4). 185–191. 12 indexed citations

Janetzko, Karin, et al.. (2002). Storage Characteristics of Split Double-Dose Platelet Concentrates Derived from Apheresis and Treated with Amotosalen Hydrochloride and UVA Light for Pathogen Inactivation. Transfusion Medicine and Hemotherapy. 29(4). 193–198. 19 indexed citations

10.

Knutson, Folke, et al.. (2000). Photochemical Inactivation of Bacteria and HIV in Buffy–Coat–Derived Platelet Concentrates under Conditions That Preserve in vitro Platelet Function. Vox Sanguinis. 78(4). 209–216. 78 indexed citations

11.

Rhenen, D.J. van, et al.. (2000). Functional Characteristics of S-59 Photochemically Treated Platelet Concentrates Derived from Buffy Coats. Vox Sanguinis. 79(4). 206–214. 89 indexed citations

12.

Rhenen, D.J. van, et al.. (2000). Functional Characteristics of S‐59 Photochemically Treated Platelet Concentrates Derived from Buffy Coats. Vox Sanguinis. 79(4). 206–214. 79 indexed citations

13.

Knutson, Folke, Kent Dupuis, V. Mayaudon, et al.. (2000). Photochemical Inactivation of Bacteria and HIV in Buffy‐Coat‐Derived Platelet Concentrates under Conditions That Preserve in vitro Platelet Function. Vox Sanguinis. 78(4). 209–216. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact